Aliskiren/hydrochlorothiazide, sold under the brand name Tekturna HCT among others, is a fixed-dose combination medication for the treatment of hypertension (high blood pressure). Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. It contains aliskiren, a renin inhibitor, and hydrochlorothiazide, a diuretic. It is taken by mouth.
The most common side effect is diarrhea.
Aliskiren/hydrochlorothiazide was approved for medical use in the United States in January 2008, and for use in the European Union in January 2009.
Medical uses Aliskiren/hydrochlorothiazide is indicated for the treatment of essential hypertension in adults.
References
External links